Literature DB >> 11477658

Molecular cytogenetic definition of three distinct chromosome arm 14q deletion intervals in gastrointestinal stromal tumors.

M Debiec-Rychter1, R Sciot, P Pauwels, E Schoenmakers, P Dal Cin, A Hagemeijer.   

Abstract

Gastrointestinal stromal tumors (GISTs) are mesenchymal neoplasms characterized by frequent chromosome arm 14q losses. In this study, the 14q changes in a series of 39 histologically and immunohistochemically confirmed GISTs were analyzed in detail by metaphase and/or interphase fluorescence in situ hybridization (FISH) studies using 21 genetically well-characterized, region-specific 14q11-24 YAC clones. By conventional cytogenetic analysis, acquired clonal chromosome aberrations were found in 17 out of 35 tumors. Chromosome 14 was involved in 13 cases; six specimens showed complete chromosome 14 loss, while the remaining seven had structural abnormalities with the breakpoints residing within the intervals 14q11-13 or 14q22-24. Other recurrent chromosome aberrations included frequent deletions of chromosome 1p (11/17), losses of chromosome 22 (7/17), losses or deletions of chromosome arm 13 (6/17) or 15 (4/17), and gains or translocations involving chromosome 17 (4/17). Combining cytogenetic data with double-color FISH analysis, total or partial losses of 14q material were detected in 29 out of 36 tumors (81%). The 14q losses were found in all stages and histological subtypes. Two most frequent common deletion regions flanked by YACs 931B1 and 761D4, and 802E7 and 892C11 at 14q23-24 (25/30 of each; 83%) could be identified. Furthermore, 21 tumors (70%) shared a region of deletion defined by YACs 957H10 and 931E5 at 14q11-12. Our results suggest the presence of at least three distinct critical deletion regions on chromosome 14 in GISTs. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11477658     DOI: 10.1002/gcc.1163

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

1.  Cloning, expression and chromosomal assignment of human pleckstrin 2.

Authors:  Tetsuya Inazu; Asato Kuroiwa; Yoichi Matsuda; Kaoru Miyamoto
Journal:  Mol Biol Rep       Date:  2005-03       Impact factor: 2.316

Review 2.  An update on molecular genetics of gastrointestinal stromal tumours.

Authors:  L Tornillo; L M Terracciano
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

3.  Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53.

Authors:  Chad Deisenroth; Aaron R Thorner; Takeharu Enomoto; Charles M Perou; Yanping Zhang
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

4.  The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors.

Authors:  Johanna Andersson; Helene Sjögren; Jeanne M Meis-Kindblom; Göran Stenman; Pierre Aman; Lars-Gunnar Kindblom
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

5.  Loss of 14q chromosome in oligodendroglial and astrocytic tumors.

Authors:  Charles Dichamp; Sophie Taillibert; Lucinda Aguirre-Cruz; Julie Lejeune; Yannick Marie; Michèle Kujas; Jean-Yves Delattre; Khe Hoang-Xuan; Marc Sanson
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

Review 6.  Genetic progression in gastrointestinal stromal tumors: mechanisms and molecular interventions.

Authors:  Ke Li; Haibo Cheng; Zhang Li; Yuzhi Pang; Xiaona Jia; Feifei Xie; Guohong Hu; Qingping Cai; Yuexiang Wang
Journal:  Oncotarget       Date:  2017-03-08

7.  Dehydrogenase/reductase SDR family member 2 silencing sensitizes an oxaliplatin‑resistant cell line to oxaliplatin by inhibiting excision repair cross‑complementing group 1 protein expression.

Authors:  Ji-Min Li; Guan-Min Jiang; Liang Zhao; Fang Yang; Wei-Qi Yuan; Hao Wang; Yi-Qin Luo
Journal:  Oncol Rep       Date:  2019-08-22       Impact factor: 3.906

8.  DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma.

Authors:  Y Zhou; L Wang; X Ban; T Zeng; Y Zhu; M Li; X-Y Guan; Y Li
Journal:  Oncogene       Date:  2017-11-06       Impact factor: 9.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.